Yousif Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History
Yousif Capital Management, LLC
- $8.31 Billion
- Q1 2025
A detailed history of Yousif Capital Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 17,605 shares of PCRX stock, worth $477,799. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,605
Previous 18,059
2.51%
Holding current value
$477,799
Previous $340,000
28.82%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.5MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$143 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$88.6 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$61.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$54.1 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.24B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...